Although renal denervation didn’t go down so well for the management of refractory hypertension, that doesn’t mean the problem has gone away. This new randomised controlled trial is about trying something a little different – and the early results look promising. Check it out at the Lancet, here.
We all know that ischaemic heart disease is a risk factor for AF, through multiple mechanisms, however how about AF as a risk factor for having an MI?
Turns out AF doubles your risk (1.7 after adjustment for major risk factors). This association was stronger in women, and not significant in the older age group.
It’s not just strokes – AF is becoming a serious public health issue, and one we don’t know enough about. Read more at JAMA Internal Medicine.
image | Wikimedia Commons
source | JAMA Internal Medicine
To everyone who reads here at medjuice, thanks for your support and regular visits and I hope you all have a wonderful Christmas and a good break leading into a new year. There are a lot more medical breakthroughs coming this year – it’s going to be exciting. See you all in the new year!
One of the most common conditions in the world, and yet despite the vast array of medications we have, the treatment of hypertension is still exceedingly variable. To even up the stakes, here is the latest guideline from the Americans on the management of hypertension.
Read it here.
Statins are now an essential part of the therapy for ischaemic heart disease, but what’s their role in primary prevention? This review of the evidence in this month’s JAMA gives a great overview. Continue reading
The recent AHA meetings have provided a littany of articles to look at, with the most recent coming in an online first form over at the New England Journal of Medicine. This topic however has been looked at before (ASTRAL and STAR), and now this new trial titled CORAL aims to put the argument to bed once and for all. Continue reading